ClinicalTrials.Veeva

Menu

Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Germ Cell Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT02303015
DaTeCa01

Details and patient eligibility

About

The purpose of this study is to identify genetic variations in survivors of testicular cancer and connect these variations to differences in risks of late effects.

Full description

Identification of late-effects through questionnaires and linkage to national registries. DNA samples will be gathered through buccal swabs or saliva kits and analysed with whole exome-sequencing.

Enrollment

430 patients

Sex

Male

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Danish citizen
  • Diagnosed with germ cell cancer from 1984 to 2007
  • Treated initially at a Danish hospital
  • Treated with standard treatment regimens.

Exclusion criteria

  • Treated initially at a foreign hospital

Trial design

430 participants in 1 patient group

Danish germ cell cancer patients
Description:
Danish patients with germ cell cancer diagnosed from 1984 to 2007.

Trial contacts and locations

1

Loading...

Central trial contact

Jakob Lauritsen, M.D.; Gedske Daugaard, M.D., DMSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems